Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures

Folia Histochemica et Cytobiologica

Volumn 38, Issue 3, 2000, Pages 119-127

  Fazekas, I ^a   Bacsy E ^b,d   Varga, I ^c   Slowik, F ^a   Balint K ^a   Pasztor E ^a   Czirjak S ^a   Glaz E ^c  

^a NATIONAL INSTITUTE OF NEUROSURGERY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Cell culture; Growth hormone; Pituitary adenoma; Prolactic; Vasoactive intestinal polypeptide

Indexed keywords

GROWTH HORMONE; PROLACTIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; CELL CULTURE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROLACTIN RELEASE; PROLACTINOMA;

EID: 0033940742     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Arnaout MA, Garthwaite TL, Martinson DR, Hagen TC (1986) Vasoactive intestinal polypeptide is synthesized in anterior pituitary tissue. Endocrinology 119: 2052-2057
2. Bácsy E, Fazekas I, Slowik F, Pásztor E, Czirják S (1997a) Transformation of a human mixed GH-PRL adenoma cell population in response to long-term bromocriptine treatment. Folia Histochem Cytobiol 35: 69-74
3. Bácsy E, Fazekas I, Pásztor E (1997b) Fine-structural and immunocytochemical analysis of human somatotropic and mammotropic adenoma cell cultures. Folia Histochem Cytobiol 35, Suppl 2: 29
4. Bryant MG, Bloom SR, Polak JM, Albuquerque RH, Modlin I, Pearse AGE (1976) Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet 1: 991-993
5. Byrne JM, Jones PM, Hill SF, Bennet WM, Ghatei MA, Bloom SR (1992) Expression of messenger ribonucleic acids encoding neuropeptide-Y, substance-P, and vasoactive intestinal polypeptide in human pituitary. J Clin Endocrinol Metab 75: 983-987
6. Chihara K, Iwasaki J, Minamitani N, Kaji H, Matsukura S, Tamaki N, Matsumoto S, Fujita T (1982) Effect of vasoactive intestinal polypeptide on growth hormone secretion in perifused acromegalic pituitary adenoma tissues. J Clin Endocrinol Metab 54: 773-779
7. Denef C, Baes M, Schramme C (1986) Paracrine interactions in the anterior pituitary: Role in the regulation of prolactin and growth hormone secretion. In: Frontiers in Neuroendocrinology, Vol. 9. Ganong WF, Martini L [Eds], Raven Press, New York, pp 115-148
8. +, TRH and VIP on the electrophysiological properties of pituitary cells in culture. Neuroendocrinol Lett 4:245-252
9. Emson PC, Fahrenkrug J, DeMuckadell OBS, Jessel TM, Iversen LL (1978) Vasoactive intestinal polypeptide (VIP) vesicular localization and potassium evoked release from rat hypothalamus. Brain Res 143 :174-178
10. Enjalbert A, Arancibia S, Ruberg M, Priam M, Bluet-Pajot MT, Rotsztejn WH, Kordon C (1980) Stimulation of in vitro prolactin release by vasoactive intestinal peptide. Neuroendocrinology 31: 200-204
11. Fazekäs I, Pásztor E, Slowik F, Bálint K, Dobronyi I, Bácsy E, Gyévai A, Péter F, Blatniczky L, Varga I, Gláz E (1993) Pathological and experimental investigations in a case of gigantism. Acta Neuropathol 85: 167-174
12. Gazsó L, Pásztor E (1980) Growth characteristics of human pituitary adenomas in tissue and cell cultures. Acta Neuropathol 49: 225-230
13. Giannattasio G, Bassetti M (1990) Human pituitary adenomas. Recent advances in morphological studies. J Endocrinol Invest 13: 435-454
14. Hsu DW, Riskind PN, Hedley-Whyte ET (1989) Vasoactive intestinal peptide in the human pituitary gland and adenomas. Am J Pathol 135: 329-338
15. Larsson LI, Fahrenknig J, Schaffalitzky de Muckadell OB, Sundler F, Hakanson R, Rehfeld JF (1976) Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons. Proc Natl Acad Sci USA 73: 3197-3200
16. Li J, Stefaneanu L, Kovacs K, Horvath E, Smyth HS (1993) Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas. Virchows Arch A Pathol Anat Histopathol 422: 193-201
17. Malarkey WB, O'Dorisio TM, Kennedy M, Cataland S (1981) The influence of vasoactive intestinal polypeptide and cholecystokinin on prolactin release in rat and human monolayer cultures. Life Sci 28: 2489-2495
18. Martin JB, Renaud LP, Brazeau P (1974) Pulsatile growth hormone secretion: suppression by hypothalamic ventromedial lesions and by long acting somatostatin. Science 186: 538-540
19. Matsushita N, Kato Y, Katakami H, Shimatsu A, Yanaihara N, Imura H (1981) Stimulation of growth hormone release by vasoactive intestinal polypeptide from human pituitary adenomas in vitro. J Clin Endocrinol Metab 53: 1297-1300
20. Morel G, Besson J, Rosselin G, Dubois PM (1982) Ultrastructural evidence for endogenous vasoactive intestinal peptide-like immunoreactivity in the pituitary gland. Neuroendocrinology 34: 85-89
21. Nagy G, Mulchahey JJ, Neill JD (1988) Autocrine control of prolactin secretion by vasoactive intestinal peptide. Endocrinology 122: 364-366
22. Nicosia S, Spada A, Borghi C, Cortelazzi L, Giannattasio G (1980) Effects of vasoactive intestinal polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomas. Stimulation of PRL release and activation of adenylate cyclase. FEBS Lett 112: 159-162
23. Said SI, Mutt V (1970) Polypeptide with broad biological activity: isolation from small intestine. Science 169: 1217-1218
24. Said SI, Porter JC (1979) Vasoactive intestinal polypeptide: release into hypophyseal portal blood. Life Sci 24: 227-230
25. Shaar CJ, Clemens JA, Dininger NB (1979) Effect of vasoactive intestinal polypeptide on prolactin release in vitro. Life Sci 25: 2071-2074
26. Shimatsu A, Kato Y, Matsushita N, Katakami H, Yanaihara N, Imura H (1981) Immunoreactive vasoactive intestinal polypeptide in rat hypophyseal portal blood. Endocrinology 108: 395-398
27. Spada A, Nicosia S, Cortelazzi L, Pezzo G, Bassetti M, Sartorio A, Giannattasio G (1983) In vitro studies on prolactin release and adenylate cyclase activity in human prolactin-secreting pituitary adenomas. Different sensitivity of macro-and microadenomas to dopamine and vasoactive intestinal polypeptide. J Clin Endocrinol Metab 56: 1-10
28. Sporn MB, Todaro GJ (1980) Autocrine secretion and malignant transformation of cells. New Engl J Med 303: 878-880
29. White MC, Adams EF, Loizou M, Mashiter K (1982) Vasoactive intestinal peptide stimulates adrenocorticotropin release from human corticotropinoma cells in culture: Interaction with arginine vasopressin and hydrocortisone. J Clin Endocrinol Metab 55: 967-972